drugset / Trial / NCT04742816

Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients

NCT04742816

Phase 4 Completed 42 enrolled University of California, San Diego
NaSingle-groupOpen-labelDiagnostic

Summary

Will use a subset of the main study cohort of transgender or non-binary individuals to evaluate the relationships between self-reported exogenous hormone use, endogenous hormone values, renal biomarkers, drug levels and directly measured renal function.

Timeline

Start
2020-09-17
Primary completion
2021-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Iohexol Diagnostic / imaging agent 0.5 ml Subcutaneous

Indications

No indication recorded.